You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 9,907,868


✉ Email this page to a colleague

« Back to Dashboard


Title:Process for the preparation of complexes of .sup.68Ga
Abstract: A process for the preparation of complexes containing .sup.68Ga wherein a buffer formic acid/formate in the presence of compounds capable to sequester metal cations is used in the complexation reaction.
Inventor(s): Fugazza; Lorenza (San Fiorano, IT), Filannino; Maria Azzurra (Bertinoro, IT), Mariani; Maurizio Franco (Ivrea, IT)
Assignee: Advanced Accelerator Applications International S.A. (Geneva, CH)
Filing Date:May 24, 2016
Application Number:15/163,484
Claims:1. A process for the preparation of complexes of .sup.68Ga, wherein the complexing reaction between a chelator-functionalized molecule selected from the group consisting of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tretraacetic acid ("DOTA"); 1,4,7-triazacyclononane-1,4,7-triyltriacetic acid ("NOTA"); and 3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene-3,6,9-triacet- ic acid ("PCTA") and .sup.68Ga is carried out in a buffered aqueous solution, selected from the group consisting of acetate buffer, HEPES buffer, lactate buffer, tartrate buffer, and carbonate buffer in the presence of a compound capable of sequestering metal cations selected from the group consisting of glycine and other chelating amino acids, crown ethers and nitrogen crown ethers, heterocyclic organic compounds, calixarenes, polydentate chelators, natural chelating agents, catechins, tannins, porphyrinin, and linear or macrocyclic chelating agents, and wherein said compound able to sequester metal cations is added at the beginning of the complexing reaction.

2. The process according to claim 1, wherein the complexing reaction is carried out in a pH range between 3 and 4.5.

3. The process according to claim 2, wherein the reaction is carried out in a pH range between 3.2 and 4.2.

4. The process according to claim 2, wherein the reaction is carried out in a pH range between 3.4 and 4.0.

5. The process according to claim 1, wherein a commercial generator of .sup.68Ga is eluted with an eluate containing an acid directly into a vial containing the buffered aqueous solution; a chelator-functionalized molecule is added into the vial; the reaction vial is heated for a short time; and complexes of .sup.68Ga are collected.

6. The process according to claim 1, wherein a commercial generator of .sup.68Ga is eluted with an eluate containing an acid directly into a vial containing a chelator-functionalized molecule; the buffered aqueous solution is added into the vial; the reaction vial is heated for a short time; and complexes of .sup.68Ga are collected.

7. The process according to claim 6 wherein the acid eluate is an aqueous solution of HCl, and the base is an aqueous solution of NaOH.

8. Complexes of .sup.68Ga obtained by the process according to claim 1, characterized in that they contain less than 10 mg/ml buffered aqueous solution and less than 100 nmols of the compound capable of sequestering metal cations.

9. A reaction kit comprising: a first vial containing a chelator-functionalized molecule and a compound capable of sequestering metal cations; and a second vial or a syringe containing a ultra-pure buffered aqueous solution.

10. The reaction kit according to claim 9, wherein said first and second vials are siliconized vials.

11. A vial containing a chelator-functionalized molecule, a compound capable of sequestering metal cations, and an ultra-pure buffered aqueous solution.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.